Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/1997
08/26/1997US5660984 DNA isolating apparatus comprising a non-porous DNA binding, anion exchange resin and methods of use thereof
08/26/1997US5660983 Maize cytoplasmic male sterility type T (cms-T) mitochondria DNA
08/26/1997US5660981 Selection of diagnostic genetic markers in microorganisms and use of a specific marker for detection of salmonella
08/26/1997US5660980 Methods for identifying and isolating variant T4 DNA polymerases
08/26/1997US5660979 Using rna amplification, determining the hybridization
08/26/1997US5660855 Administering an aminomannose derivatized cholesterol for the restenosis prevention after angioplasty treatment
08/26/1997US5660812 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system
08/26/1997US5659984 Adapted to be attached to a vehicle
08/26/1997CA2063855C Precision and accuracy of anion-exchange separation of nucleic acids
08/26/1997CA1339365C Oligopeptides and intermediates and processes for their manufacture
08/26/1997CA1339364C Prochymosin expression plasmids useful in .beta. subtilis
08/26/1997CA1339363C Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
08/26/1997CA1339359C Hybrid protein and fused gene encoding gene
08/26/1997CA1339358C Process for the preparation of motilin-like polypeptide and expression thereof
08/26/1997CA1339357C Gap gene sequences and diagnostic uses thereof
08/26/1997CA1339356C Human platelet-derived growth factor receptor
08/26/1997CA1339355C Cloning vectors for streptomyces and use thereof in macrolide antibioticproduction
08/26/1997CA1339354C Recombinant retroviruses with amphotropic and ecotropic host ranges
08/26/1997CA1339353C Macromolecular conjugate
08/26/1997CA1339352C Artificial dna base pair analogues
08/26/1997CA1339350C Monoclonal antibody kc-57 to hiv core proteins
08/26/1997CA1339349C Bacterial extracellular lignin peroxidase
08/26/1997CA1339346C Recombinant chimeric vaccine
08/22/1997CA2198160A1 Enzyme with leudh activity, nucleotide sequence coding therefor and process for the preparation of the enzyme
08/22/1997CA2197524A1 Polyketide synthase genes
08/21/1997WO1997030354A2 Foetal cell analysis
08/21/1997WO1997030178A2 Diagnosing trinucleotide repeat diseases and genes involved therein
08/21/1997WO1997030177A2 Process for recognizing the risk of becoming ill after an arthropod bite
08/21/1997WO1997030170A1 Composition for the transfection of higher eucaryotic cells
08/21/1997WO1997030169A1 10a1 retroviral packaging cells and uses thereof
08/21/1997WO1997030168A1 Regulatable retrovirus system for genetic modification of cells
08/21/1997WO1997030167A1 Method of treating liver disorders
08/21/1997WO1997030166A1 Microspore-specific promoter from tobacco
08/21/1997WO1997030165A2 Method for the induction of genetic parthenocarpy in plants
08/21/1997WO1997030164A1 Improvements in or relating to gene expression
08/21/1997WO1997030163A1 Plants having enhanced nitrogen assimilation/metabolism
08/21/1997WO1997030162A1 Regulation of gene expression in eukaryotes
08/21/1997WO1997030161A1 Hybrid proteins which form heterodimers
08/21/1997WO1997030160A1 Esterases
08/21/1997WO1997030159A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
08/21/1997WO1997030158A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
08/21/1997WO1997030157A1 Novel human myeloid terminal differentiation response gene
08/21/1997WO1997030156A2 NUCLEOTIDES AND PEPTIDES CORRESPONDING TO THE CANINE IgE HEAVY CHAIN CONSTANT REGION AND RELATED METHODS
08/21/1997WO1997030155A1 Gene therapy method using fgf-5
08/21/1997WO1997030154A1 Nucleotide sequence from goat liver
08/21/1997WO1997030153A1 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas
08/21/1997WO1997030152A1 Separation of single stranded and double stranded nucleic acid materials
08/21/1997WO1997030151A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation
08/21/1997WO1997030150A2 Molecules for the induction of immunological tolerance
08/21/1997WO1997030149A1 Novel era
08/21/1997WO1997030084A1 Tnf receptor death domain ligand proteins and inhibitors of ligand binding
08/21/1997WO1997030083A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
08/21/1997WO1997030074A1 Isolation and use of sh3 binding peptides
08/21/1997WO1997030070A1 Novel compounds
08/21/1997WO1997030065A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/21/1997WO1997030064A1 Hexitol containing oligonucleotides and their use in antisense strategies
08/21/1997WO1997030062A1 Isolation and amplification of nucleic acid materials
08/21/1997WO1997030058A1 Phosphatidyl oligoglycerols
08/21/1997WO1997030024A2 Lipids and their use, for example, in liposomes
08/21/1997WO1997029780A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression
08/21/1997WO1997029772A1 Recombinant canine herpesviruses
08/21/1997WO1997029771A1 Immunogenic detoxified mutants of cholera toxin
08/21/1997WO1997029766A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
08/21/1997WO1997029765A1 Antimicrobial peptides and methods of use
08/21/1997WO1997029757A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections
08/21/1997WO1997023650A3 Method for evaluation of polymorphic genetic sequences, and the use thereof in identification of hla types
08/21/1997WO1997023613A3 Cell activation process and reagents therefor
08/21/1997WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
08/21/1997WO1997022972A3 Method for the simultaneous detection of a therapeutic target for a disease state and its neutralizing antibody-like molecule
08/21/1997WO1997017369A3 Dna comprising a neuron-specific transcriptional promoter and its use in a gene therapy vector
08/21/1997WO1997014806A3 Delivery of biologically active polypeptides
08/21/1997WO1996040937A3 Adenosine kinase polynucleotides
08/21/1997DE19622224A1 Phosphatidyloligoglycerine Phosphatidyloligoglycerols
08/21/1997DE19545468A1 Increasing yield of riboflavin in microbial cultures
08/21/1997CA2749312A1 Sugar-modified gapped oligonucleotides
08/21/1997CA2259456A1 Regulation of gene expression in eukaryotes
08/21/1997CA2247246A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/21/1997CA2246737A1 Esterases
08/21/1997CA2246712A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation
08/21/1997CA2246578A1 Novel human myeloid terminal differentiation response gene
08/21/1997CA2246503A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections
08/21/1997CA2246414A1 Improvements in or relating to gene expression
08/21/1997CA2246372A1 Foetal cell analysis
08/21/1997CA2246362A1 Diagnosing trinucleotide repeat diseases and genes involved therein
08/21/1997CA2246276A1 Method for the induction of genetic parthenocarpy in plants
08/21/1997CA2246230A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression
08/21/1997CA2246227A1 Composition for the transfection of higher eucaryotic cells
08/21/1997CA2246223A1 Nucleotide sequence from goat liver
08/21/1997CA2245877A1 Hybrid proteins which form heterodimers
08/21/1997CA2245761A1 Microspore-specific promoter from tobacco
08/21/1997CA2245727A1 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
08/21/1997CA2245503A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
08/21/1997CA2244800A1 Immunogenic detoxified mutants of cholera toxin
08/21/1997CA2244663A1 10a1 retroviral packaging cells and uses thereof
08/21/1997CA2243662A1 Recombinant canine herpesviruses
08/21/1997CA2243562A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
08/21/1997CA2242660A1 Antimicrobial peptides and methods of use
08/21/1997CA2242381A1 Regulatable retrovirus system for genetic modification of cells
08/21/1997CA2241802A1 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
08/21/1997CA2197847A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of borna disease virus, nucleic acid fragments coding therefor and their use for diagnostic and immunization purposes